USP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.922580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.223800E-01
Normal-vs-Stage2
2.507800E-01
Normal-vs-Stage3
2.187600E-01
Normal-vs-Stage4
6.274400E-01
Stage1-vs-Stage2
4.613400E-01
Stage1-vs-Stage3
9.234800E-01
Stage1-vs-Stage4
2.989800E-01
Stage2-vs-Stage3
4.780200E-01
Stage2-vs-Stage4
5.525800E-01
Stage3-vs-Stage4
3.860800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.713040E-01
Normal-vs-AfricanAmerican
3.165000E-01
Normal-vs-Asian
5.914200E-01
Caucasian-vs-AfricanAmerican
6.852400E-01
Caucasian-vs-Asian
6.522400E-01
AfricanAmerican-vs-Asian
9.261600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.298400E-01
Normal-vs-Female
1.670620E-01
Male-vs-Female
6.723600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.120800E-01
Normal-vs-Age(41-60Yrs)
3.469200E-01
Normal-vs-Age(61-80Yrs)
1.338230E-01
Normal-vs-Age(81-100Yrs)
3.616400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.122000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.604600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.853800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.100250E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.669200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.889800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.162800E-01
Normal-vs-Daily Drinker
1.972230E-01
Normal-vs-Weekly Drinker
4.657700E-02
Normal-vs-Occasional Drinker
5.539900E-02
Normal-vs-Social Drinker
8.347900E-02
Non Drinker-vs-Daily Drinker
6.067600E-01
Non Drinker-vs-Weekly Drinker
1.744760E-01
Non Drinker-vs-Occasional Drinker
4.251800E-01
Non Drinker-vs-Social Drinker
5.623200E-01
Daily Drinker-vs-Weekly Drinker
3.609400E-01
Daily Drinker-vs-Occasional Drinker
8.559800E-01
Daily Drinker-vs-Social Drinker
9.302000E-01
Weekly Drinker-vs-Occasional Drinker
3.496000E-01
Weekly Drinker-vs-Social Drinker
3.439400E-01
Occasional Drinker-vs-Social Drinker
9.203800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.026200E-01
Normal-vs-Grade 2
2.640500E-02
Normal-vs-Grade 3
2.155600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.601700E-02
Grade 1-vs-Grade 3
3.981600E-02
Grade 1-vs-Grade 4
1.026200E-01
Grade 2-vs-Grade 3
8.827600E-01
Grade 2-vs-Grade 4
2.640500E-02
Grade 3-vs-Grade 4
2.155600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.050200E-02
Normal-vs-NonDiabetic
2.083800E-01
Diabetic-vs-NonDiabetic
4.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.880000E-01
Normal-vs-NoPancreatitis
1.405420E-01
Pancreatitis-vs-NoPancreatitis
8.612100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.972380E-01
Normal-vs-N1
2.195400E-01
N0-vs-N1
3.729600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.372000E-01
Normal-vs-TP53-NonMutant
2.718600E-01
TP53-Mutant-vs-TP53-NonMutant
1.583760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
